Dashboard
Discussions
Watchlists
Collections
More
Events
Tools
SIGN UP
SIGN IN
bullish
Bloomage Biotechnology Lt
Watchlist
Bloomage Biotechnology (688363.CH) - Positioning and Strategic Layout Imply Strong Upside Potential
Synthetic biology/industrial chain integration help Bloomage build high moat.Synergy of multiple business improve the resilience to market changes.Don't underestimate Bloomage so you don't miss alpha.
Equity Bottom-Up
161 Views
17 Oct 2022 08:50
SUMMARY
(Sign Up to Access)
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
Unlimited Research Summaries
Personalised Alerts
Custom Watchlists
Company Analytics & News
Events & Webinars
Trusted by:
SMARTKARMA PREVIEW PASS
Sign Up with LinkedIn
or
First Name
Last name
Email
Sign Up with Email
By signing up, you agree to our
Terms of Use
and
Privacy Policy
.
Trusted by:
Already have an account?
Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
China
Health Care
Equity Bottom-Up
Thematic (Sector/Industry)
View Full Profile
Price Chart
(Sign Up to Access)
Insight Stream
China Healthcare - A Pair Trade: Long Sino Biopharm (1177.HK), Short Hengrui Medicine (600276.CH)
27 Oct 2022
Pre-IPO Giant Biogene (2367 HK) - Some Unstable Factors
26 Oct 2022
CanSino Biologics Inc (688185.CH/6185.HK) - Some Positive Progress in Business
19 Oct 2022
Bloomage Biotechnology (688363.CH) - Positioning and Strategic Layout Imply Strong Upside Potential
17 Oct 2022
Pre-IPO Giant Biogene - The Strength and the Concerns
13 Oct 2022
Bloomage Biotechnology Vs Yunnan Botanee Bio-Technology - Accumulate Richly and Break Forth Vastly
24 May 2022
Bloomage Biotechnology (688363.CH) Vs Imeik Technology (300896.CH) - The Logic and the Outlook
11 Jan 2022
Top
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.18.2
x